High levels of urinary complement proteins are associated with chronic renal damage and proximal tubule dysfunction in immunoglobulin A nephropathy.

Nephrology
Lu WenJon W Gregersen

Abstract

Complement activation is involved in the pathogenesis and progression of immunoglobulin A nephropathy (IgAN); however, the clinical implication of abnormal complement protein levels in serum and urine is not clear. To address this we analyzed the correlation between disease activity and complement proteins in serum and urine from IgAN patients, and compared to patients with other types of chronic kidney disease (CKD) as well as healthy controls. We included 85 Chinese patients with IgAN, 23 patients with non-proliferative CKD, and 20 healthy individuals. Patients were divided according to the Oxford classification of M0E0S0T0 (group 1, n = 20), M1E1S0-1 T0-1 (group 2, n = 25), M1E1S0-1 T2 or M0E0S1T1-2 (group 3, n = 40). Complement factor H (CFH), mannose-binding lectin and membrane attack complex in serum and urine were measured by enzyme-linked immunosorbent assay. Urinary CFH, membrane attack complex and serum CFH were increased in both IgAN and CKD patients compared with healthy controls. The urinary excretion of CFH was the highest in IgAN patients with most tubulointerstitial damage (IgAN group 3). Urinary CFH and mannose-binding lectin levels were significantly higher in IgAN patients with crescents formation (C1-2) than...Continue Reading

References

Jan 1, 1988·Virchows Archiv. A, Pathological Anatomy and Histopathology·H MiyamotoS Maki
Aug 27, 1998·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·M EndoT Fujita
Oct 9, 1999·The American Journal of Pathology·J R LehesteT E Willnow
Mar 22, 2001·Kidney International·W ZhouS H Sacks
Jan 29, 2008·Seminars in Nephrology·François C BerthouxAïda Afiani
Oct 10, 2008·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Mario EspinosaPedro Aljama
May 6, 2009·Annals of Internal Medicine·Andrew S LeveyUNKNOWN CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration)
Jul 3, 2009·Kidney International·UNKNOWN Working Group of the International IgA Nephropathy Network and the Renal Pathology SocietyHong Zhang
Sep 29, 2011·Journal of the American Society of Nephrology : JASN·Hitoshi SuzukiBruce A Julian
Jun 21, 2013·The New England Journal of Medicine·Robert J Wyatt, Bruce A Julian
Oct 29, 2013·Seminars in Nephrology·Marina Noris, Giuseppe Remuzzi
Feb 20, 2015·Journal of the American Society of Nephrology : JASN·Nicolas MaillardJan Novak
Nov 15, 2015·Journal of Nephrology·Mohamed R Daha, Cees van Kooten
Sep 11, 2016·Journal of the American Society of Nephrology : JASN·Mark HaasRitsuko Katafuchi
Mar 28, 2017·Kidney International·Hernán TrimarchiUNKNOWN Conference Participants

❮ Previous
Next ❯

Citations

Apr 1, 2021·Journal of Cellular and Molecular Medicine·Lufeng BaiMinghui Zhao

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alternative Complement Pathway

The Alternative Complement Pathway is part of the innate immune system, and activation generates membrane attack complexes that kill pathogenic cells. Discover the latest research on the Alternative Complement Pathway.

Antibodies: Complement Activation

The complement system can be activated by antigen-associated antibody. In the classical pathway of complement activation, C1q, C4b, and C3b are all able to bind to the Fc portion of IgG or IgM. Find the latest research on antibodies and complement activation here.